Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06949098 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer

StatusRecruiting
PhasePhase 2
Started2025-05-15
View on ClinicalTrials.gov ↗

Amendment history

2026-07-31
Study Status v2
Re-verified, no change to tracked fields
2025-05-28
Study Status, Eligibility v1
Start dateestimated 2025-04→confirmed 2025-05-15
Eligibility criteria+9 characters
[...] sal to undergo abdominoperineal resection (Miles operation) MeetsThe indicationssurgeon fordetermined a local excisionresection surgerywas feasible No contraindications to chemoradiotherapy Exclusion Criteri [...]
2025-04-22
Original filing
This study is a single-center, single-arm, prospective clinical trial designed to evaluate the efficacy of local excision followed by postoperative chemoradiotherapy in patients with early-stage low/ultra-low rectal cancer. The study plans to enroll 60 patients with T1-2N0M0 low/ultra-low rectal cancer.
Trial Details
NCT Number NCT06949098
Lead Sponsor Hebei Medical University Fourth Hospital
Conditions Rectal Cancer Stage I
Enrollment 60 participants
Start Date 2025-05-15
Primary Completion 2032-03 (estimated)
Study Completion 2032-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-03